Pharmatest is proud to participate in the ASBMR Annual Meeting 2025 and the 2025 ASBMR/RBDA Symposium on Rare Bone Diseases: From the Genome to the Lived Experience, Seattle Convention Center, September 4–8, 2025.
Poster Presentation
Title:
Increased Proliferation and Osteoblastic Differentiation of Mesenchymal Stem Cells in +/G610C Mouse Model of Adult Osteogenesis Imperfecta
Symposium on Rare Bone Diseases Poster ID: PM-134, September 4, 2025
ASBMR Poster ID: SAT-281, September 6, 2025 2:00 PM – 3:30 PM
Interested in advancing your research in rare bone diseases?
Schedule a meeting with our CEO Jukka Rissanen to explore how Pharmatest can support your preclinical studies with cutting-edge models and analytical tools.
ASBMR2025 RareDiseases BoneDiseases CRO PreclinicalResearch Pharmatest
